UiPath Inc. (NASDAQ:PATH) shares saw strong trading volume on Thursday after BMO Capital Markets raised their price target on the stock from $80.00 to $85.00. BMO Capital Markets currently has a market perform rating on the stock. 117,150 shares traded hands during trading, a decline of 96% from the previous session’s volume of 2,689,342 shares.The stock last traded at $71.25 and had previously closed at $68.71.
A number of other brokerages have also weighed in on PATH. Wolfe Research initiated coverage on UiPath in a research note on Monday, May 17th. They set a “peer perform” rating and a $70.00 price target on the stock. Mizuho started coverage on UiPath in a research note on Monday, May 17th. They set a “buy” rating and a $77.00 price target on the stock. Wells Fargo & Company started coverage on UiPath in a research report on Monday, May 17th. They issued an “equal weight” rating and a $75.00 target price on the stock. Truist Securities increased their target price on UiPath from $80.00 to $82.00 and gave the stock a “buy” rating in a research report on Wednesday. Finally, Truist increased their target price on UiPath from $80.00 to $82.00 and gave the stock a “buy” rating in a research report on Wednesday. Eleven equities research analysts have rated the stock with a hold rating and eight have given a buy rating to the company. The company presently has a consensus rating of “Hold” and an average price target of $76.89.
In other news, major shareholder East Fund 2013 Sca Sic Digital sold 2,100,400 shares of UiPath stock in a transaction that occurred on Friday, April 23rd. The stock was sold at an average price of $56.00, for a total transaction of $117,622,400.00. Also, CEO Daniel Dines sold 1,383,168 shares of UiPath stock in a transaction that occurred on Friday, April 23rd. The shares were sold at an average price of $56.00, for a total value of $77,457,408.00. Insiders sold 5,011,241 shares of company stock worth $280,629,496 in the last three months.
UiPath (NASDAQ:PATH) last announced its earnings results on Monday, June 7th. The healthcare company reported $0.02 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.05) by $0.07.
UiPath Company Profile (NASDAQ:PATH)
UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, and Japan. It develops UiPath Studio, a platform designed for RPA developers looking to build complex process automations with built-in governance capabilities, such as robust debugging tools, application programming interface automation, wizards to automate desktop or web applications, leverage custom code, and to integrate machine learning models into production workflows.
Recommended Story: Earnings Reports
Receive News & Ratings for UiPath Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UiPath and related companies with MarketBeat.com's FREE daily email newsletter.